Mostrando 3 resultados de: 3
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(3)
ODS 10: Reducción de las desigualdades(1)
ODS 8: Trabajo decente y crecimiento económico(1)
ODS 9: Industria, innovación e infraestructura(1)
Origen
scopus(3)
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 (Nature Structural & Molecular Biology, (2020), 27, 9, (846-854), 10.1038/s41594-020-0469-6)
OtherAbstract: In the version of this article initially published, author Jiandong Huo’s name was spelt incorrectlyPalabras claves:Autores:Bas A.L., Buttigieg K.R., Carrique L., Carroll M.W., Clare D.K., Coombes N., Dumoux M., Duyvesteyn H.M.E., Elmore M.J., Harrison P.J., Huo J., James W.S., Javier Gilbert Jaramillo, Knight M.L., Malinauskas T., Mikolajek H., Moynié L., Naismith J.H., Owens R.J., Radecke J., Ren J., Rijal P., Ruza R.R., Shah P.N.M., Stuart D.I., Tan T.K., Townsend A.R., Tree J.A., Vogirala V.K., Ward P.N., Weckener M., Zhao Y., Zhou D.Fuentes:scopusStructural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
ArticleAbstract: The COVID-19 pandemic has had an unprecedented health and economic impact and there are currently noPalabras claves:Autores:Buttigieg K.R., Carrique L., Carroll M.W., Chen C.P., Chen T.H., Cheng C.Y., Cheng S.H., Donat R.F., Duyvesteyn H.M.E., Fry E.E., Godwin K., Huang C.G., Huang K.Y.A., Huang Y.C., Huo J., James W.S., Javier Gilbert Jaramillo, Knight M.L., Lin T.Y., Lin Y.C., Ma C., Malinauskas T., Mongkolsapaya J., Naismith J.H., Owens R.J., Paterson N.G., Radecke J., Ren J., Rijal P., Ruza R.R., Screaton G.R., Shah P.N.M., Shih S.R., Stuart D.I., Supasa P., Tan T.K., Townsend A.R., Tree J.A., Zhao Y., Zhou D.Fuentes:scopusStructures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
ArticleAbstract: Background: Administration of potent anti-receptor-binding domain (RBD) monoclonal antibodies has bePalabras claves:Antibody cocktail, Antibody-antigen complex, Human monoclonal antibody, In vitro and in vivo function, Receptor-binding domain epitope, SARS-COV-2Autores:Buttigieg K.R., Carroll M.W., Charlton S., Chen C., Chen C.P., Chen X., Cheng S.H., Donat R.F., Duyvesteyn H.M.E., Fry E.E., Ginn H.M., Harding A.C., Huang K.Y.A., James W.S., Javier Gilbert Jaramillo, Lien C.E., Lin M.Y., Lin T.Y., Ma C., Qin L., Ren J., Rijal P., Schimanski L., Stuart D.I., Tan T.K., Townsend A.R., Tree J.A., Zhao Y., Zhou D.Fuentes:scopus